-
公开(公告)号:US11927573B2
公开(公告)日:2024-03-12
申请号:US17156939
申请日:2021-01-25
Applicant: CYTIVA BIOPROCESS R&D AB
Inventor: Klaus Gebauer
CPC classification number: G01N30/6004 , B01D15/18 , B01D15/206 , B01D15/22 , G01N30/56 , G01N30/606 , G01N30/8658 , G01N2030/565 , G01N30/6017 , G01N30/6021 , G01N30/6052
Abstract: The present invention relates to axial flow chromatography columns, methods for separating one or more analytes in a liquid by the use of such columns, and systems employing such columns. The column comprises a first port and a second port, the first port and said second port being at essentially the same level or elevation above the level of the bed space on the chromatography column.
-
公开(公告)号:US20230040131A1
公开(公告)日:2023-02-09
申请号:US17938653
申请日:2022-10-06
Applicant: Cytiva BioProcess R&D AB
Inventor: Klaus Gebauer
Abstract: A parallel assembly of chromatography column modules, the assembly having one common assembly inlet and one common assembly outlet, each column module comprising a bed space filled with chromatography medium and each column module comprises integrated fluid conduits which when the column module is connected with other column modules are adapted to connect the bed space of the column module with the assembly inlet and the assembly outlet, wherein the total length and/or volume of the fluid conduit from the assembly inlet to one bed space together with the length and/or volume of the fluid conduit from the same bed space to the assembly outlet is substantially the same for all bed spaces and modules installed in the parallel assembly.
-
公开(公告)号:US11542300B2
公开(公告)日:2023-01-03
申请号:US15564232
申请日:2016-04-04
Applicant: Cytiva BioProcess R&D AB
Inventor: Martin Hall , Karolina Busson , Jean-Luc Maloisel , Helena Skoglar
IPC: C07K1/18 , B01J41/20 , B01D15/36 , B01D15/38 , A61K38/36 , A61K38/48 , A61K35/16 , C12N9/64 , B01D15/34 , C07K14/47 , C07K14/755 , C07K14/765 , C07K16/00 , A61K38/00
Abstract: The present invention relates to the field of chromatography. More closely, the invention relates to a chromatographic method for purification of plasmaproteins, such as Factor VIII, von Willebrand factor and Factor IX. The chromatographic method is performed on a matrix comprising an inner porous core and outer porous lid surrounding said core.
-
公开(公告)号:US11491417B2
公开(公告)日:2022-11-08
申请号:US17125645
申请日:2020-12-17
Applicant: Cytiva BioProcess R&D AB
Inventor: Klaus Gebauer
Abstract: A parallel assembly of chromatography column modules, the assembly having one common assembly inlet and one common assembly outlet, each column module comprising a bed space filled with chromatography medium and each column module comprises integrated fluid conduits which when the column module is connected with other column modules are adapted to connect the bed space of the column module with the assembly inlet and the assembly outlet, wherein the total length and/or volume of the fluid conduit from the assembly inlet to one bed space together with the length and/or volume of the fluid conduit from the same bed space to the assembly outlet is substantially the same for all bed spaces and modules installed in the parallel assembly.
-
公开(公告)号:US20220111310A1
公开(公告)日:2022-04-14
申请号:US17544700
申请日:2021-12-07
Applicant: Cytiva Bioprocess R&D AB
Inventor: Karol Maciej Lacki , Hans Blom , Helena Skoglar , Linus Laurin
Abstract: The invention discloses a separation matrix comprised of porous spherical particles to which antibody-binding protein ligands have been covalently immobilized, wherein the density of said ligands is in the range of 10.5-15 mg/ml and the volume-weighted median diameter of said particles is in the range of 30-55 μm.
-
公开(公告)号:US11136359B2
公开(公告)日:2021-10-05
申请号:US15900419
申请日:2018-02-20
Applicant: Cytiva BioProcess R&D AB
Inventor: Gustav Rodrigo , Mats Ander , Tomas Bjorkman , Goran Bauren
IPC: C07K14/31 , B01D15/38 , B01J20/286 , B01J20/32 , C07K1/22 , C07K14/745 , C07K16/00
Abstract: The invention discloses a polypeptide with improved alkaline stability, which polypeptide comprises a mutant of a B or C domain of Staphylococcus Protein A (SpA), as specified by SEQ ID NO 1 or SEQ ID NO 2, or of Protein Z, as specified by SEQ ID NO 3, wherein at least the glutamine residue at position 9 has been mutated to an amino acid other than asparagine. The invention also discloses multimers of said polypeptide, as well as separation matrices comprising the multimers or polypeptides.
-
公开(公告)号:US11027250B2
公开(公告)日:2021-06-08
申请号:US16328129
申请日:2017-09-04
Applicant: Cytiva BioProcess R&D AB
Inventor: Jimmy Hedin Dahlstrom , Jonas Bengtsson , Per Erik Emilsson , Maranda Fordham , Eva Holmgren , Ronnie Palmgren , Fernando Polanco
Abstract: A system and method for producing fine droplets of polysaccharide from a premixed water-in-oil emulsion uses a packed bed (5) comprising hydrophilic beads (7).
-
公开(公告)号:US10995113B2
公开(公告)日:2021-05-04
申请号:US16893574
申请日:2020-06-05
Applicant: Cytiva BioProcess R&D AB
Inventor: Gustav José Rodrigo , Tomas Bjorkman , Mats Ander , Jesper Ulf Hansson
IPC: A23J1/00 , C07K1/22 , B01D15/38 , B01J20/24 , B01J20/28 , B01J20/286 , B01J20/32 , C07K14/31 , C07K16/00 , C07K16/06 , C07K17/10
Abstract: The invention relates to a separation matrix comprising at least 11 mg/ml Fc-binding ligands covalently coupled to a porous support, wherein: a) the ligands comprise multimers of alkali-stabilized Protein A domains, and b) the porous support comprises cross-linked polymer particles having a volume-weighted median diameter (d50,v) of 56-70 micrometers and a dry solids weight of 55-80 mg/ml.
-
公开(公告)号:US20250153140A1
公开(公告)日:2025-05-15
申请号:US18839374
申请日:2023-02-16
Applicant: Cytiva BioProcess R&D AB
Inventor: Jean-Luc Maloisel , Frederic Leroux , Lisa Marx
Abstract: A chromatography medium is provided, comprising a matrix of cellulose-based nanofibers, the nanofibers optionally being crosslinked to one another. A ligand coupled to the matrix without any intermediate extender group. Also provided is a method of preparing a functionalised chromatography medium. The method comprises: (i) providing a substrate comprising cellulose acetate; (ii) forming a fibrous matrix/membrane spun of nanofibers from the substrate; (iii) saponification of the nanofibers to form regenerated cellulose nanofibers; (iv) derivatisation of the regenerated cellulose nanofibers with a cross-linker, and (v) coupling of a ligand to the derivatised cellulose nanofibers, wherein the preparation of the functionalised chromatography medium does not comprise any surface extender. The chromatography medium is useful for separation of large analytes, such as viruses.
-
公开(公告)号:US20250058298A1
公开(公告)日:2025-02-20
申请号:US18712580
申请日:2022-12-06
Applicant: Cytiva BioProcess R&D AB
Inventor: Jean-Luc Maloisel , Åsa Hagner McWhirter , Ola Lind , Ida Helena Vestin , Erik Tingborn , Björn Norén
IPC: B01J20/28 , B01J20/24 , B01J20/282 , B01J20/32
Abstract: The present disclosure is directed to a separation matrix comprising a plurality of chromatography particles, each chromatography particle comprising a core and a layer surrounding the core, wherein the core has a first average pore diameter and the layer surrounding the core has a second average pore diameter, wherein the second average pore diameter is at least 1.5 times higher than the first average pore diameter, wherein the first average pore diameter excludes diffusion of a target molecule through the pores of the core and wherein the second average pore diameter at least partly permits diffusion of the target molecule through the pores of the layer surrounding the core. Further disclosed are a method for preparing such a separation matrix, uses of such a separation matrix and methods for separating target molecules by use of such a separation matrix, in particular a method for separating adeno associated virus capsids fully packaged with genetic material from adeno associated virus capsids not fully packaged with genetic material, and compositions obtained by said method.
-
-
-
-
-
-
-
-
-